Therefore, exploring the underlying mechanism of FoxO1 activity in the pathogenesis of PCOS will help provide a novel target for establishing the treatment of PCOS and associated complications (Figure 1). This evidence concerns the gene FOXO1 and polycystic ovary syndrome.